Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study

27. maj 2021 opdateret af: Els Knippenberg, PXL University College
Rehabilitation technology is more and more implemented in conventional therapy to increase the dosage of therapy and/or increase patient's motivation towards therapy. In orthopedic as well as neurological rehabilitation it is important to exercise with enough intensity and repetitions to improve functional performance in activities of daily life, and consequently quality of life. At the moment, not all (rehabilitation) technologies are adapted towards the wishes and needs of both patients and therapists for everyday use in the clinical setting. Also, not all technologies are fit for independent use by the patients. Researcher of PXL have developed a Kinect-based system (i.e. i-ACT) for rehabilitation and performed supervised research with i-ACT in neurological and musculoskeletal rehabilitation, and older adults. Within this research, patients will exercise with i-ACT under supervision of their therapist during weekdays, but in the weekends they will be motivated by the medical staff to perform their exercises with i-ACT. The medical staff will be present for safety reasons, but the patient is asked to use and exercise with i-ACT as independent as possible. The aim of this research is to explore to which extend i-ACT is suitable for semi-independent use by patients in orthopedic or neurological rehabilitation.

Studieoversigt

Status

Ikke rekrutterer endnu

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Forventet)

40

Fase

  • Fase 2
  • Fase 1

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • age over 18 years old
  • post-operation of arthroplasty (hip or knee), or official medical diagnosis of stroke or Parkinson's disease
  • understand Dutch instructions
  • patient at St-Trudo ziekenhuis
  • experiencing problems in functional performance

Exclusion Criteria:

  • neglect
  • spasticity (Brunström Fugl-Meyer < 50)
  • cognitive disfunction (Mini Mental State Examination < 24)
  • visual impairment (blind, cataract, etc.)
  • persons who are not able to exit electric wheelchair

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Arthroplasty, hip or knee
Minimum 5x/week (of which minimal 3x/week with therapists and 2x/week during weekend), 30-60 minutes training, for 4 weeks, with i-ACT system. i-ACT provides individualised exercises based on patients own goalsetting.
i-ACT is a Microsoft Kinect-based system that provides individualised exercises based on patients own goalsetting.
Eksperimentel: Neurology: stroke or Parkinson disease
Minimum 5x/week (of which minimal 3x/week with therapists and 2x/week during weekend), 30-60 minutes training, for 4 weeks, with i-ACT system. i-ACT provides individualised exercises based on patients own goalsetting.
i-ACT is a Microsoft Kinect-based system that provides individualised exercises based on patients own goalsetting.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Canadian Occupational Performance Measure
Tidsramme: Baseline
The Canadian Occupational Performance Measure (COPM) is an evidence-based outcome measure designed to capture a client's self-perception of performance in everyday living, over time. Scores range from 0 to 10 (best score) in each defined goal.
Baseline
Canadian Occupational Performance Measure
Tidsramme: 4 weeks
The Canadian Occupational Performance Measure (COPM) is an evidence-based outcome measure designed to capture a client's self-perception of performance in everyday living, over time. Scores range from 0 to 10 (best score) in each defined goal.
4 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
System Usability Scale
Tidsramme: 4 uger
Brugbarhed af et system, i denne i-ACT. Interval af score fra 0 (negativ) til 100 (positiv).
4 uger
Wolf Motor funktionstest
Tidsramme: Baseline
Arm-hånd funktion. Testen indeholder 17 punkter og scores fra 0 (ikke i stand til at udføre prøve) til 5 (normal præstation).
Baseline
Wolf Motor funktionstest
Tidsramme: 4 uger
Arm-hånd funktion. Testen indeholder 17 punkter og scores fra 0 (ikke i stand til at udføre prøve) til 5 (normal præstation).
4 uger
Intrinsic Motivation Inventory
Tidsramme: 1 week
The Intrinsic Motivation Inventory (IMI) is a multidimensional measurement questionnaire intended to assess participants' subjective experience with, in this, i-ACT. The IMI consists of 6 subscales in which a person scores on a scale from 1 (totally not true) to 7 (totally true). Some scores need to be reversed by subtracting the response score from 8. A total IMI-score is not recommended, therefore subscale scores are used in the analyses. A higher score means a higher level of the aspect of the subscale.
1 week
Intrinsic Motivation Inventory
Tidsramme: 4 weeks
The Intrinsic Motivation Inventory (IMI) is a multidimensional measurement questionnaire intended to assess participants' subjective experience with, in this, i-ACT. The IMI consists of 6 subscales in which a person scores on a scale from 1 (totally not true) to 7 (totally true). Some scores need to be reversed by subtracting the response score from 8. A total IMI-score is not recommended, therefore subscale scores are used in the analyses. A higher score means a higher level of the aspect of the subscale.
4 weeks
System Usability Scale
Tidsramme: 1 week
Usability of a system, in this i-ACT. Range of scores from 0 (negative) to 100 (positive).
1 week
Timed Up and Go test
Tidsramme: Baseline
The time between a person standing up from a chair, walking 3 meters before turning around and walking back to sit back in the chair.
Baseline
Timed Up and Go test
Tidsramme: 4 weeks
The time between a person standing up from a chair, walking 3 meters before turning around and walking back to sit back in the chair.
4 weeks
2 Minute Walking Test
Tidsramme: Baseline
This is a measure of the distance a person can walk in 2 minutes.
Baseline
2 Minute Walking Test
Tidsramme: 4 weeks
This is a measure of the distance a person can walk in 2 minutes.
4 weeks
Barthel Index
Tidsramme: Baseline
The Barthel Index measures the degree of assistance required by an individual on 10 items of mobility and self care ADL. Scores range from 0 to 100.
Baseline
Barthel Index
Tidsramme: 4 weeks
The Barthel Index measures the degree of assistance required by an individual on 10 items of mobility and self care ADL. Scores range from 0 to 100.
4 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Forventet)

1. september 2021

Primær færdiggørelse (Forventet)

1. juni 2022

Studieafslutning (Forventet)

1. juli 2022

Datoer for studieregistrering

Først indsendt

26. maj 2021

Først indsendt, der opfyldte QC-kriterier

26. maj 2021

Først opslået (Faktiske)

28. maj 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

1. juni 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. maj 2021

Sidst verificeret

1. maj 2021

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • Exploration in St-Trudo

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

All collected IPD that underlie results in a possible publication will be shared.

IPD-delingstidsramme

Starting 3 months after publication.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ja

produkt fremstillet i og eksporteret fra U.S.A.

Ja

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med i-ACT

3
Abonner